Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
NCT05981911 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2026-01-02
Summary
The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.
Conditions
Interventions
- DEVICE
-
XIENCE Skypoint™ stent
Percutaneous coronary intervention with Xience-Skypoint™ stent
Sponsors & Collaborators
-
CardioVascular Research Foundation, Korea
collaborator OTHER -
Seung-Jung Park
lead OTHER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-14
- Primary Completion
- 2026-06-30
- Completion
- 2026-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)
NCT01605721 ·Status: UNKNOWN ·Phase: PHASE4
-
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
NCT00485030 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Drug Eluting Balloon and Drug Eluting Stent
NCT01539603 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)
NCT01350869 ·Status: COMPLETED
-
Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis
NCT01967199 ·Status: TERMINATED ·Phase: PHASE4
-
CONNECT DES Registrty
NCT04715594 ·Status: UNKNOWN
-
Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)
NCT01348399 ·Status: COMPLETED
-
Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System
NCT05477940 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)
NCT01515228 ·Status: COMPLETED ·Phase: PHASE4
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
NCT01078038 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
NCT00638794 ·Status: COMPLETED
-
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
NCT03507205 ·Status: COMPLETED
-
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
NCT00960908 ·Status: UNKNOWN
-
The Clinical Efficacy and Safety of Drug-coated Balloon
NCT05133921 ·Status: COMPLETED
-
LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)
NCT01489761 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial
NCT03589157 ·Status: UNKNOWN ·Phase: NA
-
Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study
NCT03567733 ·Status: COMPLETED
-
DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold
NCT03074305 ·Status: WITHDRAWN ·Phase: NA
-
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
NCT05846893 ·Status: RECRUITING ·Phase: NA
-
Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis
NCT03151018 ·Status: UNKNOWN
-
Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus
NCT00997763 ·Status: COMPLETED ·Phase: PHASE4
-
Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)
NCT01078051 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)
NCT05656118 ·Status: ACTIVE_NOT_RECRUITING
-
Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial
NCT01196819 ·Status: COMPLETED ·Phase: NA
-
Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients
NCT05937230 ·Status: ACTIVE_NOT_RECRUITING